Table 1 Comparing Demographics, Anticholinergic Burden and Polypharmacy between Delirium and No-delirium Groups
Study Population (n = 251) | Delirium (n = 125) | No-delirium (n = 122) | Significance | |
|---|---|---|---|---|
Mean Age (years, SD) | 83.97 (±6.60) | 84.4 (±6.52) | 83.54 (±6.67) | p = 0.21 |
Female (%) | 67.3 | 62.4 | 72.4 | p = 0.95 |
Median Length of Stay (days, IQR) | 10 (3–20) | 15 (6–29) | 6 (2–13) | p < 0.001 |
Median drugs prescribed | 7.00 (5–10) | 7.00 (5–10) | 7.00 (5–10) | p = 0.72 |
Polypharmacy (%) | 79.8 | 79.2 | 80.5 | p = 0.80 |
Excessive Polypharmacy (%) | 29.0 | 28.8 | 29.3 | p = 0.94 |
Median ACB score | 1.00 (0–2) | 1.00 (0–3) | 1.00 (1–2) | P = 0.58 |
ACB score ≥1 (%) | 73.4 | 68.8 | 78.0 | p = 0.10 |
Median ADS score | 1.50 (0–3) | 1.00 (0–2.5) | 2.00 (1–3) | p = 0.09 |
ADS score ≥1 (%) | 73.0 | 67.2 | 78.9 | p = 0.39 |
AChE Inhibitor prescribed (%) | 5.6 | 8.8 | 2.4 | p = 0.030 |